Exploiting ROS and metabolic differences to selectively killing cisplatin resistant lung cancer

被引：0
作者：
Wangpaichitr, Medhi
Wu, Chunjing
Li, Ying Ying
Shah, Sumedh
Chen, Shu-Mei
Dinh, Vy
Kuo, Macus T.
Feun, Lynn G.
Savaraj, Niramol
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1038
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Identification of a prognostic gene signature in patients with cisplatin resistant squamous cell lung cancer
    Mu, Yi
    Dong, Yinan
    Zheng, Mingyang
    Barr, Martin P.
    Roviello, Giandomenico
    Hu, Zhihuang
    Liu, Jia
    [J]. JOURNAL OF THORACIC DISEASE, 2024, 16 (07) : 4567 - 4583
  • [32] Effects of Nivolumab and Ipilimumab on the suppression of cisplatin resistant small cell lung cancer cells
    Wei Chi
    Lianyong Zhang
    Xue Wang
    Jingjing Li
    Fei Li
    Yuxia Ma
    Qianyun Zhang
    [J]. Investigational New Drugs, 2022, 40 : 709 - 717
  • [33] Pemetrexed combined with cisplatin for patients with EGFR-TKI resistant advanced lung cancer
    Zhou, Zunyan
    Yang, Jiyuan
    Li, Hongtao
    Luo, Fei
    Shao, Chengze
    Wang, Qian
    Du, Wei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (07): : 8678 - 8685
  • [34] Cisplatin resistant non small cell lung cancer is sensitive to arginine deprivation therapy
    Wangpaichitr, Medhi
    Wu, Chunjing
    Nguyen, Dao M.
    You, Min
    Li, Ying Ying
    Chen, Shumei
    Feun, Lynn G.
    Savaraj, Niramol
    [J]. CANCER RESEARCH, 2015, 75
  • [35] Effects of Nivolumab and Ipilimumab on the suppression of cisplatin resistant small cell lung cancer cells
    Chi, Wei
    Zhang, Lianyong
    Wang, Xue
    Li, Jingjing
    Li, Fei
    Ma, Yuxia
    Zhang, Qianyun
    [J]. INVESTIGATIONAL NEW DRUGS, 2022, 40 (04) : 709 - 717
  • [36] Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
    Lin, Jessica J.
    Langenbucher, Adam
    Gupta, Pranav
    Yoda, Satoshi
    Fetter, Isobel J.
    Rooney, Marguerite
    Do, Andrew
    Kem, Marina
    Chang, Kylie Prutisto
    Oh, Audris Y.
    Chin, Emily
    Juric, Dejan
    Corcoran, Ryan B.
    Dagogo-Jack, Ibiayi
    Gainor, Justin F.
    Stone, James R.
    Lennerz, Jochen K.
    Lawrence, Michael S.
    Hata, Aaron N.
    Mino-Kenudson, Mari
    Shaw, Alice T.
    [J]. NPJ PRECISION ONCOLOGY, 2020, 4 (01)
  • [37] Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
    Jessica J. Lin
    Adam Langenbucher
    Pranav Gupta
    Satoshi Yoda
    Isobel J. Fetter
    Marguerite Rooney
    Andrew Do
    Marina Kem
    Kylie Prutisto Chang
    Audris Y. Oh
    Emily Chin
    Dejan Juric
    Ryan B. Corcoran
    Ibiayi Dagogo-Jack
    Justin F. Gainor
    James R. Stone
    Jochen K. Lennerz
    Michael S. Lawrence
    Aaron N. Hata
    Mari Mino-Kenudson
    Alice T. Shaw
    [J]. npj Precision Oncology, 4
  • [38] Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle
    Gumulec, Jaromir
    Balvan, Jan
    Sztalmachova, Marketa
    Raudenska, Martina
    Dvorakova, Veronika
    Knopfova, Lucia
    Polanska, Hana
    Hudcova, Kristyna
    Ruttkay-Nedecky, Branislav
    Babula, Petr
    Adam, Vojtech
    Kizek, Rene
    Stiborova, Marie
    Masarik, Michal
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (03) : 923 - 933
  • [39] Exploiting vulnerabilities to nanoparticle induced lipid peroxidation and proteotoxicity to treat drug resistant lung cancer
    Snyder, Christina
    Rohde, Monica
    Singh, Ravi N.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [40] Golden Berry-Derived 4β-hydroxywithanolide E for Selectively Killing Oral Cancer Cells by Generating ROS, DNA Damage, and Apoptotic Pathways
    Chiu, Chien-Chih
    Haung, Jo-Wen
    Chang, Fang-Rong
    Huang, Kuang-Jing
    Huang, Hsuan-Min
    Huang, Hurng-Wern
    Chou, Chon-Kit
    Wu, Yang-Chang
    Chang, Hsueh-Wei
    [J]. PLOS ONE, 2013, 8 (05):
12345